Nicotinamide adenine dinucleotide (NAD+) is one of the most important molecules in your cells. It acts as a coenzyme, meaning it helps enzymes do their jobs. At its core, NAD+ is essential for:
Research consistently shows that NAD+ levels fall as we get older. This is not just a lab finding: in humans, lower NAD+ has been associated with neurodegenerative disease, insulin resistance, heart failure, and even increased cancer risk (Verdin, 2015; Covarrubias et al., 2020; Abdellatif et al., 2021).
One reason is increased activity of enzymes that use up NAD+:
The combination of reduced NAD+ production and increased consumption leads to lower cellular energy, weaker DNA repair, and less resilience to stress.
Animal studies suggest that replenishing NAD+ through dietary precursors such as nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) improves muscle strength, metabolism, and even cognitive performance. Lifestyle strategies like exercise and caloric restriction also raise NAD+.
Early human trials have found that NR and NMN supplementation can increase blood NAD+ levels and appear safe, but results on actual health outcomes are still preliminary. A 2023 review in The Journals of Gerontology highlighted the need for longer, well-controlled trials to determine whether NAD+ boosters truly improve aging-related outcomes in people (Freeberg et al., 2023).
Currently, NAD+ is not part of routine blood panels but specialized labs have developed assays that measure NAD⁺ and related molecules (like NADH and NADPH) from a blood sample.